EP2178540A4 - Composition pharmaceutique destinée à être adsorbée sur la surface cellulaire de microbes pathogènes - Google Patents

Composition pharmaceutique destinée à être adsorbée sur la surface cellulaire de microbes pathogènes

Info

Publication number: EP2178540A4
Authority: EP; European Patent Office
Prior art keywords: adsorption; pharmaceutical composition; cell surface; composition suitable; pathogenic microbes
Prior art date: 2007-08-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP08779458A

Other languages

German (de)

English (en)

Other versions

EP2178540A1 (fr

Inventor

Stellan Hjerten

Marie-Christine Hjerten

Torkel Wadstroem

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-01

Filing date

2008-07-30

Publication date

2012-01-04

2008-07-30 Application filed by Individual filed Critical Individual

2010-04-28 Publication of EP2178540A1 publication Critical patent/EP2178540A1/fr

2012-01-04 Publication of EP2178540A4 publication Critical patent/EP2178540A4/fr

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Epidemiology (AREA)
Medicinal Preparation (AREA)

EP08779458A 2007-08-01 2008-07-30 Composition pharmaceutique destinée à être adsorbée sur la surface cellulaire de microbes pathogènes Withdrawn EP2178540A4 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US95324407P	2007-08-01	2007-08-01
PCT/SE2008/050901 WO2009017456A1 (fr)	2007-08-01	2008-07-30	Composition pharmaceutique destinée à être adsorbée sur la surface cellulaire de microbes pathogènes

Publications (2)

Publication Number	Publication Date
EP2178540A1 EP2178540A1 (fr)	2010-04-28
EP2178540A4 true EP2178540A4 (fr)	2012-01-04

Family

ID=40304563

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP08779458A Withdrawn EP2178540A4 (fr)	2007-08-01	2008-07-30	Composition pharmaceutique destinée à être adsorbée sur la surface cellulaire de microbes pathogènes

Country Status (2)

Country	Link
EP (1)	EP2178540A4 (fr)
WO (1)	WO2009017456A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2013015738A1 (fr) *	2011-07-22	2013-01-31	HJERTÉN, Maria	Capture de bioparticules et de biopolymères pathogènes et non pathogènes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5382434A (en) *	1991-03-12	1995-01-17	Akzo N.V.	Low steroid dose dry pharmaceutical preparation
WO2001008792A2 (fr) *	1999-07-30	2001-02-08	Genentech, Inc.	Membranes de filtration chargees et utilisations associees

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9203435D0 (sv) *	1992-11-11	1992-11-11	Georg Vlatakis Fondation For R	Framstaellande av artificiella antikroppar med molekylavtrycksmetoden samt deras anvaendning vid analys
US5728296A (en) *	1996-03-20	1998-03-17	Bio-Rad Laboratories, Inc.	Selective recognition of solutes in chromatographic media by artificially created affinity
US5846943A (en) *	1996-11-08	1998-12-08	Synsorb Biotech, Inc.	Solid support matricles containing a toxin binding oligosaccharide
AU2002364491A1 (en) *	2002-01-03	2003-07-30	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Edible compositions capable of removing oral biofilm
PT1635661E (pt) *	2003-06-13	2010-11-17	Torkel Wadstroem	Produto para fins de absorção

2008
- 2008-07-30 WO PCT/SE2008/050901 patent/WO2009017456A1/fr not_active Ceased
- 2008-07-30 EP EP08779458A patent/EP2178540A4/fr not_active Withdrawn

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5382434A (en) *	1991-03-12	1995-01-17	Akzo N.V.	Low steroid dose dry pharmaceutical preparation
WO2001008792A2 (fr) *	1999-07-30	2001-02-08	Genentech, Inc.	Membranes de filtration chargees et utilisations associees

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2009017456A1 *

Also Published As

Publication number	Publication date
WO2009017456A1 (fr)	2009-02-05
EP2178540A1 (fr)	2010-04-28

Similar Documents

Publication	Publication Date	Title
IL207955A0 (en)	2010-12-30	Boron - containing small molecules as anti - inflammatory agents
EP2212248A4 (fr)	2015-07-08	Procédé de préparation du graphène
IL201891A0 (en)	2010-06-16	Novel pharmaceutical composition
IL228817A0 (en)	2013-12-31	Pharmaceutical compounds
ZA201004217B (en)	2011-02-23	Use of bacteria for the production of bioenergy
PL3329912T3 (pl)	2025-12-01	Ciekła kompozycja
PT2374452T (pt)	2019-10-31	Composição de nutrientes
ZA201100653B (en)	2011-10-26	Topical composition for the treatment of ctinic keratosis
GB0803124D0 (en)	2008-03-26	Improvements relating to benefit particles
ZA201102715B (en)	2012-07-25	Solid pharmaceutical composition
ZA201001774B (en)	2010-12-29	Enriched nanostructure composition
EP2431038A4 (fr)	2014-01-15	Composition pharmaceutique comprenant de l'arbidol sous forme de nanoparticules de phospholipides
IL208387A0 (en)	2010-12-30	Pharmaceutical composition
ZA201006766B (en)	2011-05-25	Pharmaceutical composition 271
IL211567A0 (en)	2011-05-31	Use of stem cells to prevent neuronal dieback
ZA201100871B (en)	2012-05-30	Solid pharmaceutical composition
GB0818025D0 (en)	2008-11-05	Granular composition
GB0714790D0 (en)	2007-09-12	Improvements in or relating to organic compounds
ZA201006224B (en)	2011-11-30	Pharmaceutical composition
GB201015043D0 (en)	2010-10-27	Novel napthalimide-benzimidazole hybrids as potential antitumour agents and process for the preparation thereof
GB2464200B (en)	2013-05-08	Pharmaceutical composition
EP2178540A4 (fr)	2012-01-04	Composition pharmaceutique destinée à être adsorbée sur la surface cellulaire de microbes pathogènes
PL386709A1 (pl)	2009-06-08	Kompozycja oczyszczająca
GB0817969D0 (en)	2008-11-05	Pharmaceutical composition
GB0709886D0 (en)	2007-07-04	Improvements in or relating to organic compounds

Legal Events

Date	Code	Title	Description
2010-03-26	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2010-04-28	17P	Request for examination filed	Effective date: 20100216
2010-04-28	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
2010-04-28	AX	Request for extension of the european patent	Extension state: AL BA MK RS
2010-11-10	DAX	Request for extension of the european patent (deleted)
2012-01-04	A4	Supplementary search report drawn up and despatched	Effective date: 20111206
2012-01-04	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 9/14 20060101ALI20111130BHEP Ipc: A61P 31/04 20060101ALI20111130BHEP Ipc: A61K 31/74 20060101AFI20111130BHEP Ipc: A61K 39/395 20060101ALI20111130BHEP Ipc: A61P 31/12 20060101ALI20111130BHEP
2014-03-12	17Q	First examination report despatched	Effective date: 20140206
2016-11-25	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2016-12-28	18D	Application deemed to be withdrawn	Effective date: 20160719